FDA Inspection 1255809 — Novo Nordisk US Bio Production Inc.
The FDA completed an inspection of Novo Nordisk US Bio Production Inc. on March 5, 2025 in West Lebanon, NH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 5, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- West Lebanon, NH (United States)